Protective effects of Cynara scolymus leaves extract on metabolic disorders and oxidative stress in alloxan-diabetic rats. 2017

Maryem Ben Salem, and Rihab Ben Abdallah Kolsi, and Raouia Dhouibi, and Kamilia Ksouda, and Slim Charfi, and Mahdi Yaich, and Serria Hammami, and Zouheir Sahnoun, and Khaled Mounir Zeghal, and Kamel Jamoussi, and Hanen Affes
Laboratory of pharmacology, Faculty of Medicine, University of Sfax, Avenue Majida Boulila, 3029, Sfax, Tunisia.

BACKGROUND Diabetes mellitus (DM) is associated with hyperglycemia, inflammatory disorders and abnormal lipid profiles, currently the extracts from leaves of cynara scolymus has been discovered to treat metabolic disorders and has been stated by multitudinous scientists according to a good source of polyphenols compounds. The present study aimed to evaluate the protective effect of the ethanol leaves extract of C. scolymus in alloxan induced stress oxidant, hepatic-kidney dysfunction and histological changes in liver, kidney and pancreas of different experimental groups of rats. METHODS We determinate the antioxidant activity by ABTS .+ and antioxidant total capacity (TAC) of all extracts of C. scolymus leaves, the inhibition of α-amylase activity in vitro was also investigated. Forty male Wistar rats were induced to diabetes with a single dose intraperitoneal injection (i.p.) of alloxan (150 mg/kg body weight (b.w.)). Diabetic rats were orally and daily administrated of ethanol extract from C. scolymus at two doses (200-400 mg/kg, b.w) or (12 mg/kg, b.w) with anti-diabetic reference drug, Acarbose for one month. Ethanol extract of C. scolymus effect was confirmed by biochemical analysis, antioxidant activity and histological study. RESULTS The results indicated that the ethanol extract from leaves of C. scolymus showed the highest antioxidant activity by ABTS .+ (499.43g± 39.72 Trolox/g dry extract) and (128.75 ± 8.45 mg VC /g dry extract) for TAC and endowed the powerful inhibition in vitro of α-amylase activity with IC50=72,22 ug/uL. In vivo, the results showed that ethanol extract from the leaves of C. scolymus (200-400 mg/kg) decreased significantly (p < 0.001) the α-amylase levels in serum of diabetic rats, respectively associated with significant reduction (p < 0.001) in blood glucose rate of 42,84% and 37,91% compared to diabetic groups after 28 days of treatment, a significant lowered of plasma total cholesterol (T-Ch) by 18,11% and triglyceride (TG) by 60,47%, significantly and low-density lipoproteins (LDL-C) by 37,77%, compared to diabetic rats, moreover, the administration of ethanol extract appears to exert anti-oxidative activity demonstrated by the increase of CAT, SOD and GSH activities in liver, kidney and pancreas of diabetic rats. This positive effect of the ethanol extract from C. scolymus was confirmed by histological study. CONCLUSIONS These observed strongly suggest that ethanol extract from the leaves of C. scolymus has anti-hyperglycemic properties, at least partly mediated by antioxidant and hypolipidemic effects.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D008659 Metabolic Diseases Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed) Thesaurismosis,Diseases, Metabolic,Disease, Metabolic,Metabolic Disease,Thesaurismoses
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000496 Alloxan Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
D000516 alpha-Amylases Enzymes that catalyze the endohydrolysis of 1,4-alpha-glycosidic linkages in STARCH; GLYCOGEN; and related POLYSACCHARIDES and OLIGOSACCHARIDES containing 3 or more 1,4-alpha-linked D-glucose units. Taka-Amylase A,alpha-Amylase,Alpha-Amylase Bayer,Maxilase,Mégamylase,alpha-1,4-D-Glucanglucanohydrolase,Alpha Amylase Bayer,AlphaAmylase Bayer,Taka Amylase A,TakaAmylase A,alpha 1,4 D Glucanglucanohydrolase,alpha Amylase,alpha Amylases

Related Publications

Maryem Ben Salem, and Rihab Ben Abdallah Kolsi, and Raouia Dhouibi, and Kamilia Ksouda, and Slim Charfi, and Mahdi Yaich, and Serria Hammami, and Zouheir Sahnoun, and Khaled Mounir Zeghal, and Kamel Jamoussi, and Hanen Affes
January 2016, SpringerPlus,
Maryem Ben Salem, and Rihab Ben Abdallah Kolsi, and Raouia Dhouibi, and Kamilia Ksouda, and Slim Charfi, and Mahdi Yaich, and Serria Hammami, and Zouheir Sahnoun, and Khaled Mounir Zeghal, and Kamel Jamoussi, and Hanen Affes
May 2017, Environmental science and pollution research international,
Maryem Ben Salem, and Rihab Ben Abdallah Kolsi, and Raouia Dhouibi, and Kamilia Ksouda, and Slim Charfi, and Mahdi Yaich, and Serria Hammami, and Zouheir Sahnoun, and Khaled Mounir Zeghal, and Kamel Jamoussi, and Hanen Affes
November 2002, Life sciences,
Maryem Ben Salem, and Rihab Ben Abdallah Kolsi, and Raouia Dhouibi, and Kamilia Ksouda, and Slim Charfi, and Mahdi Yaich, and Serria Hammami, and Zouheir Sahnoun, and Khaled Mounir Zeghal, and Kamel Jamoussi, and Hanen Affes
January 1989, Annales pharmaceutiques francaises,
Maryem Ben Salem, and Rihab Ben Abdallah Kolsi, and Raouia Dhouibi, and Kamilia Ksouda, and Slim Charfi, and Mahdi Yaich, and Serria Hammami, and Zouheir Sahnoun, and Khaled Mounir Zeghal, and Kamel Jamoussi, and Hanen Affes
June 1997, Toxicology and applied pharmacology,
Maryem Ben Salem, and Rihab Ben Abdallah Kolsi, and Raouia Dhouibi, and Kamilia Ksouda, and Slim Charfi, and Mahdi Yaich, and Serria Hammami, and Zouheir Sahnoun, and Khaled Mounir Zeghal, and Kamel Jamoussi, and Hanen Affes
February 2020, Environmental science and pollution research international,
Maryem Ben Salem, and Rihab Ben Abdallah Kolsi, and Raouia Dhouibi, and Kamilia Ksouda, and Slim Charfi, and Mahdi Yaich, and Serria Hammami, and Zouheir Sahnoun, and Khaled Mounir Zeghal, and Kamel Jamoussi, and Hanen Affes
September 2013, Pharmaceutical biology,
Maryem Ben Salem, and Rihab Ben Abdallah Kolsi, and Raouia Dhouibi, and Kamilia Ksouda, and Slim Charfi, and Mahdi Yaich, and Serria Hammami, and Zouheir Sahnoun, and Khaled Mounir Zeghal, and Kamel Jamoussi, and Hanen Affes
January 2017, BMC complementary and alternative medicine,
Maryem Ben Salem, and Rihab Ben Abdallah Kolsi, and Raouia Dhouibi, and Kamilia Ksouda, and Slim Charfi, and Mahdi Yaich, and Serria Hammami, and Zouheir Sahnoun, and Khaled Mounir Zeghal, and Kamel Jamoussi, and Hanen Affes
August 2019, Journal of basic and clinical physiology and pharmacology,
Maryem Ben Salem, and Rihab Ben Abdallah Kolsi, and Raouia Dhouibi, and Kamilia Ksouda, and Slim Charfi, and Mahdi Yaich, and Serria Hammami, and Zouheir Sahnoun, and Khaled Mounir Zeghal, and Kamel Jamoussi, and Hanen Affes
July 1998, Lipids,
Copied contents to your clipboard!